Dr. Reder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S. MARYLAND AVE.
Neurology M/C 2030
Chicago, IL 60637Phone+1 773-702-6222Fax+1 773-702-9076
Education & Training
University of MinnesotaResidency, Neurology, 1978 - 1982
University of Michigan Medical SchoolClass of 1978
Certifications & Licensure
IL State Medical License 1982 - 2026- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2015
- Chicago Magazine: Top Doctors Castle Connolly, 2004, 2006, 2008, 2010, 2012, 2014
Clinical Trials
- A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS) Start of enrollment: 2007 Mar 01
- Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) Start of enrollment: 2016 Dec 01
- Mechanism of Action of Ocrelizumab in Multiple Sclerosis Start of enrollment: 2017 Oct 12
Publications & Presentations
PubMed
- 3 citationsAlternative Splicing of RNA Is Excessive in Multiple Sclerosis and Not Linked to Gene Expression Levels: Dysregulation Is Corrected by IFN-β.Anthony T Reder, Aika Goel, Tzintzuni Garcia, Xuan Feng
Journal of Interferon & Cytokine Research. 2024-08-01 - Novel biomarkers and interferon signature in secondary progressive multiple sclerosis.Avital Fogel, Maya Olcer, Aika Goel, Xuan Feng, Anthony T Reder
Journal of Neuroimmunology. 2024-04-15 - 1 citationsTwenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives.Mark S Freedman, Patricia K Coyle, Kerstin Hellwig, Barry Singer, Daniel Wynn
Neurology and Therapy. 2024-04-01
Press Mentions
Darren P. Baker, PhD a Pioneer in the Development of Pegylated Interferon-Β for Clinical UseMarch 1st, 2023
New Study Shows Extent That Interferon Affects Activity of Immune Genes in People with MSNovember 7th, 2019
New Multiple Sclerosis Treatment Offers Breakthrough for PatientsApril 20th, 2017- Join now to see all
Research History
- NMSS Sylvia Lawry and NIH FellowMentor, Jack Antel1982 - 1984
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
